Harbour Investments’s Celularity CELU Stock Holding History

Harbour Investments’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9	Hold	15	–	–	﹤0.01%	4739
2026 Q1	$20	Buy	+15	New	+$19	﹤0.01%	4623
2022 Q4	–	Sell	-120	Closed	-$4K	–	3010
2022 Q3	$4K	Hold	120	–	–	﹤0.01%	2227
2022 Q2	$4K	Buy	+120	New	+$9.75K	﹤0.01%	2227
2021 Q4	$6K	Hold	120	–	–	﹤0.01%	2090
2021 Q3	$8K	Hold	120	–	–	﹤0.01%	2754
2021 Q2	$12K	Sell	120 -520	-81%	-$52.7K	﹤0.01%	2615
2021 Q1	$65K	Buy	+640	New	+$65.6K	﹤0.01%	1515

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Harbour Investments's CELU Position: Q2 2026 in Review

Harbour Investments held its Celularity (CELU) position steady in Q2 2026 at 15 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #4739.

Harbour Investments first reported a position in CELU in Q1 2021 and has held it in 8 quarters since. The position peaked at $65K in Q1 2021. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

Harbour Investments held 15 shares of Celularity worth $9 as of Q2 2026.
Harbour Investments left its Celularity share count unchanged in Q2 2026.
Celularity made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4739 holding.
Harbour Investments first reported a position in Celularity in Q1 2021 and has held it in 8 quarters since.
Harbour Investments's Celularity position peaked at $65K in Q1 2021.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.